Pablo 125 mg (Palbociclib), general Ibrance is a traditional drug used to treat hormone receptor (HR) positive, mortal epidermal growth factor receptor 2 (HER2) negative advanced bone cancer in women who have endured menopause. Pablo is manufactured by Drug InternationalLtd. in Bangladesh.
Have to take orally formerly a day with food for 21 successive days followed by 7 days off treatment to comprise a complete cycle of 28 days.
Side Effects
The most common adverse responses are
Nausea, puking, loss of appetite, diarrhea, frazzle, weakness, hair loss, mouth blisters, or impassiveness/ tingling of arms/ legs.
The below information comes from the Internet. Please consult with the croaker for medical advice.
Suggestion
* Any advice on the use of the medicine is for reference only. Please consult with the croaker for medical advice. All Names, ensigns, and trademarks are the property of their separate possessors. Watermarks and QR canons are used for identification purposes only.
